ReferenceRRK5805

RESOLVE IT

A Multicenter Randomized Double-Blind Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis

Research Summary

Research Overview
PI Name Newsome - P
Speciality
Sponsor GENFIT
Project Status Open
Proposed End Date 31/12/2021
Study Run through CRF? Yes
Target number of patients agreed to recruit 10
Recruitment so far 2